Lacosamid-Mepha 50 mg
Lacosamid-Mepha 50 mg is a medicine authorised by Swissmedic under authorisation number 67630. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 June 2021 and the authorisation is valid without a time limit. ATC code N03AX18 places the medicine in the group Antiepileptics.
| Authorisation number | 67630 |
|---|---|
| Name | Lacosamid-Mepha 50 mg |
| Full name | Lacosamid-Mepha 50 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AX18 |
| First authorisation | 26 June 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lacosamid-Mepha 50 mg, Filmtabletten | B | 26 June 2021 |
| 2 | Lacosamid-Mepha 100 mg, Filmtabletten | B | 26 June 2021 |
| 3 | Lacosamid-Mepha 150 mg, Filmtabletten | B | 26 June 2021 |
| 4 | Lacosamid-Mepha 200 mg, Filmtabletten | B | 26 June 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 14 | Tablette(n) | N03AX18 | 01.07.1. | B |
| 2 | 14 | Tablette(n) | N03AX18 | 01.07.1. | B |
| 3 | 56 | Tablette(n) | N03AX18 | 01.07.1. | B |
| 4 | 168 | Tablette(n) | N03AX18 | 01.07.1. | B |
| 5 | 14 | Tablette(n) | N03AX18 | 01.07.1. | B |
| 6 | 56 | Tablette(n) | N03AX18 | 01.07.1. | B |
| 7 | 168 | Tablette(n) | N03AX18 | 01.07.1. | B |
| 8 | 14 | Tablette(n) | N03AX18 | 01.07.1. | B |
| 9 | 56 | Tablette(n) | N03AX18 | 01.07.1. | B |
| 10 | 168 | Tablette(n) | N03AX18 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lacosamid-Mepha 50 mg authorised in Switzerland?
Yes. Lacosamid-Mepha 50 mg is authorised by Swissmedic under authorisation number 67630, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lacosamid-Mepha 50 mg have?
Lacosamid-Mepha 50 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Lacosamid-Mepha 50 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.